Join our Whatsapp Community for Daily Price Sheets and News

DRHP Filed

Event Date: N/A

Document Summary

Veeda Clinical Research Limited (VCRL) is initiating an IPO of up to [] equity shares, with a face value of ₹2 each. The IPO consists of a fresh issue of shares aggregating up to ₹1,850.00 million and an offer for sale (OFS) of up to 13,008,128 equity shares by existing shareholders, including the promoter Basil Private Limited and other selling shareholders.

Registered Office and Contact Information:

  • Registered Office: Shivalik Plaza – A, 2nd Floor, Opposite Ahmedabad Management Association, Ambawadi, Ahmedabad 380 015, Gujarat, India.
  • Corporate Office: Satyamev Corporate, Nr. Shalin Bungalows, Corporate Road, Prahladnagar, Ahmedabad 380 015 Gujarat, India
  • Contact Person: Nirmal Atmaram Bhatia, Group Chief Financial Officer, Company Secretary and Compliance Officer; investor.relation@veedalifesciences.com; Website: www.veedalifesciences.com.

Offer Details:

  • Face Value: ₹2 per equity share
  • Offer Price: The price band, the minimum bid lot, and any revisions will be advertised in key newspapers and made available on stock exchange websites.
  • Pre-IPO Placement: VCRL may consider a pre-IPO placement of specified securities aggregating up to ₹370.00 million before filing the Red Herring Prospectus (RHP) with the RoC. The amount raised through pre-IPO placement would be reduced from the Fresh Issue.

Offer Structure & Reservations:

  • QIB Portion: Not less than 75% of the Offer (up to 60% may be allocated to Anchor Investors). 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds.
  • Non-Institutional Investors (NII): Not more than 15% of the Offer.
  • Retail Individual Investors (RII): Not more than 10% of the Offer.

Objective of the Offer: The Fresh Issue aims to utilize net proceeds for:

  • Capital expenditure on procuring equipment and machinery.
  • Investment in the Material Subsidiary (Bioneeds India Private Limited) for capital expenditure and repayment of borrowings.
  • Funding organic growth of the Company.
  • General corporate purposes.

Key Selling Shareholders:

  • Basil Private Limited (Promoter Selling Shareholder): up to 3,493,895 Equity Shares.
  • Bondway Investments Inc.: up to 7,359,620 Equity Shares.
  • Other Selling Shareholders: 22.75% from six Other Selling Shareholders.

Financial Performance (Restated Consolidated Summary): The financial information presented may not be indicative of future results. The Prospectus indicates that all key financial and accounting information is true and accurate to the best of the company's knowledge. Financial data includes information relating to Assets, Liabilities, and Equity. The summary includes performance metrics and data for specified periods.

  • The Restated Consolidated Summary Statements include details regarding Assets, Liabilities, and Equity as of specific dates including (but not limited to) September 30, 2024, September 30, 2023, March 31, 2024, March 31, 2023 and March 31, 2022.
  • The Restated Consolidated Summary Statements include details regarding Revenue, Profit and Loss, Financial Expenses, Tax Expenses and share of other comprehensive income or losses. The summary includes data for specific periods including (but not limited to) six months period ended September 30, 2024 and September 30, 2023 and for the year ended March 31, 2024, March 31, 2023, and March 31, 2022.

Key Ratios and Metrics:

  • EBITDA and Adjusted EBITDA: The summary includes details regarding calculation and levels for Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA), for key comparable periods. The Prospectus also includes details regarding the calculation of Adjusted EBITDA, a non-GAAP financial measure.
  • Revenue from Operations: Revenue from operations as per Ind AS 115.
  • Adjusted EBITDA Margin: as Adjusted EBITDA divided by Revenue from operations.
  • Risk Factors: A comprehensive section detailing risks associated with the company, its business, the industry, and the IPO itself. Specific attention of investors is invited to "Risk Factors" beginning on page 33.
  • Restated Consolidated Summary Statements: Comprise the summary statement of assets and liabilities, the statement of profit and loss (including other comprehensive income), the statement of cash flows, and the statement of changes in equity.
  • Litigation and Contingencies: Summarizes outstanding litigation and contingent liabilities as on the specified dates.
  • Related Party Transactions: Discusses transactions with related parties.

Other Information:

  • Book Running Lead Managers (BRLMs): Axis Capital Limited, CLSA India Private Limited, IIFL Capital Services Limited and SBI Capital Markets Limited are the book running lead managers for the IPO.
  • Registrar: MUFG Intime India Private Limited is the registrar to the offer.
  • Listing: Proposed listing on BSE and NSE.

This Draft Red Herring Prospectus contains forward-looking statements and a disclaimer of responsibility.

It contains risk factors, and readers are advised to read these carefully. The information is intended for general guidance only and not as a substitute for professional advice.

Our Blogs

Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.

FAQ's

What are unlisted shares?

+

Unlisted shares are stocks of companies that are not listed on any stock exchange, meaning they are not publicly traded. These shares are typically available for trade in the private market through brokers, and can offer unique investment opportunities.

How can I buy unlisted shares?

+

You can buy unlisted shares through a broker or platform that specializes in unlisted share transactions. We provide a secure and easy way to purchase unlisted shares from top companies, ensuring a smooth transaction process.

What is the share price of unlisted companies?

+

The share prices of unlisted companies can fluctuate based on various factors like market demand, company performance, and private transactions. You can check the latest share prices for unlisted companies on our website for real-time updates.

Are unlisted shares a good investment?

+

Unlisted shares can offer higher growth potential, as they are typically not subject to the same market volatility as listed shares. However, they come with higher risk due to limited liquidity and availability of information. It's important to research thoroughly and consult experts before investing.

How can I sell unlisted shares?

+

To sell unlisted shares, you can connect with a broker or platform that facilitates the sale of private stocks. We help investors buy and sell unlisted shares with ease, ensuring that your transaction is handled professionally and securely.

What are the risks of investing in unlisted shares?

+

Yes, unlisted shares can eventually be listed on a stock exchange through an Initial Public Offering (IPO). This process allows the company to offer its shares publicly and be traded on major exchanges, potentially increasing liquidity and visibility.

What is the share price of unlisted companies?

+

Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.

How do I know the current value of unlisted shares?

+

The value of unlisted shares is typically determined by private transactions, financial reports, and market demand. We provide the latest updates on share prices of unlisted companies, giving you the most accurate valuation available.

Is there a minimum investment amount for unlisted shares?

+

The minimum investment for unlisted shares can vary depending on the company and broker. Generally, the minimum investment is higher than for listed stocks, but we provide detailed information to help you make the best investment decisions.

Can I get a dividend from unlisted shares?

+

Yes, unlisted shares may pay dividends if the company has declared them. However, since these companies may be in their growth stage, dividend payments are not always guaranteed. It's important to check the company's financial health before investing.

How do I know which unlisted shares are worth investing in?

+

It's important to conduct thorough research on the company's financials, management, market potential, and overall business model. You can also seek professional advice from experts to help you choose unlisted shares with strong growth prospects.

Are unlisted shares taxed?

+

Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.

WhatsAppContact Us